Recent advances in p97/VCP/Cdc48 cellular functions

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 1, 2012, Pages 130-137

  Yamanaka, Kunitoshi ^a   Sasagawa, Yohei ^a,b   Ogura, Teru ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b RIKEN Center for Biosystems Dynamics Research   (Japan)

Author keywords

ALS; Autophagy; IBMPFD; Mitochondria; P97 VCP Cdc48; TDP 43

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE INHIBITOR; ATAXIN 3; AURORA B KINASE; CHAPERONE; HIGH MOBILITY GROUP A2 PROTEIN; POLYGLUTAMINE; PROTEASOME; PROTEIN KINASE SYK INHIBITOR; PROTEIN P97; RAPAMYCIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; VALOSIN CONTAINING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANAPHASE; AUTOPHAGOSOME; AUTOPHAGY; CAENORHABDITIS ELEGANS; CELL ACTIVITY; CELL CULTURE; CELL CYCLE; CELL FUNCTION; CELL STRESS; CHEMICAL ANALYSIS; DELETION MUTANT; DNA REPLICATION; DROSOPHILA; ENDOPLASMIC RETICULUM; EXTRACELLULAR MATRIX; FRONTOTEMPORAL DEMENTIA; GENE INTERACTION; GENETIC ANALYSIS; HERMAPHRODITIC SPECIES; HUMAN; HYPERSENSITIVITY; IN VITRO STUDY; MACHADO JOSEPH DISEASE; MEIOSIS; METAPHASE; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONHUMAN; PAGET BONE DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN PROCESSING; QUALITY CONTROL; REVIEW; SACCHAROMYCES CEREVISIAE; SEX DETERMINATION; SPERMATOGENESIS; UBIQUITINATION; X RAY CRYSTALLOGRAPHY;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL CYCLE PROTEINS; ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION; HUMANS; MITOCHONDRIA; MUTATION; MYOSITIS, INCLUSION BODY; NEOPLASMS; PROTEOLYSIS; UBIQUITINATED PROTEINS;

EID: 84855206731     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.07.001     Document Type: Review

References (144)

1. Frohlich K.U., Fries H.W., Rudiger M., Erdmann R., Botstein D., Mecke D. Yeast cell cycle protein CDC48p shows full-length homology to the mammalian protein VCP and is a member of a protein family involved in secretion, peroxisome formation, and gene expression. J. Cell Biol. 1991, 114:443-453.
2. Leon A., McKearin D. Identification of TER94, an AAA ATPase protein, as a Bam-dependent component of the Drosophila fusome. Mol. Biol. Cell 1999, 10:3825-3834.
3. Yamanaka K., Okubo Y., Suzaki T., Ogura T. Analysis of the two p97/VCP/Cdc48p proteins of Caenorhabditis elegans and their suppression of polyglutamine-induced protein aggregation. J. Struct. Biol. 2004, 146:242-250.
4. Muller J.M.M., Deinhardt K., Rosewell I., Warren G., Shima D.T. Targeted deletion of p97 (VCP/CDC48) in mouse results in early embryonic lethality. Biochem. Biophys. Res. Commun. 2007, 354:459-465.
5. Confalonieri F., Duguet M. A 200-amino acid ATPase module in search of a basic function. Bioessays 1995, 17:639-650.
6. Patel S., Latterich M. The AAA team: related ATPases with diverse functions. Trends Cell Biol. 1998, 8:65-71.
7. Ogura T., Wilkinson A.J. AAA+ superfamily ATPases: common structure-diverse function. Genes Cells 2001, 6:575-597.
8. Rouiller I., DeLaBarre B., May A.P., Weis W.I., Brunger A.T., Milligan R.A., Wilson-Kubalek E.M. Conformational changes of the multifunction p97 AAA ATPase during its ATPase cycle. Nat. Struct. Biol. 2002, 9:950-957.
9. DeLaBarre B., Brunger A.T. Complete structure of p97 valosin-containing protein reveals communication between nucleotide domains. Nat. Struct. Biol. 2003, 10:856-863.
10. Song C., Wang Q., Li C.C. ATPase activity of p97-valosin-containing protein (VCP). D2 mediates the major enzyme activity, and D1 contributes to the heat-induced activity. J. Biol. Chem. 2003, 278:3648-3655.
11. Wang Q., Song C., Li C.C. Hexamerization of p97-VCP is promoted by ATP binding to the D1 domain and required for ATPase and biological activities. Biochem. Biophys. Res. Commun. 2003, 300:253-260.
12. Wang Q., Song C., Yang X., Li C.C. D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP. J. Biol. Chem. 2003, 278:32784-32793.
13. Nishikori S., Esaki M., Yamanaka K., Sugimoto S., Ogura T. Positive cooperativity of the p97 AAA ATPase is critical for essential functions. J. Biol. Chem. 2011, 286:15815-15820.
14. Rape M., Hoppe T., Gorr L., Kalocay M., Richly H., Jentsch S. Mobilization of processes, membrane-tethered SPT23 transcription factor by CDC48 (UFD1/NPL4), ubiquitin-selective chaperone. Cell 2001, 107:667-677.
15. UFD1/NPL4 chaperone (segregase) in ERAD of OLE1 and other substrates. EMBO J. 2002, 21:615-621.
16. Halawani D., Latterich M. p97: the cell's molecular purgatory?. Mol. Cell 2006, 22:713-717.
17. Jentsch S., Rumpf S. Cdc48(p97): a "molecular gearbox" in the ubiquitin pathway?. Trends Biochem. Sci. 2007, 32:6-11.
18. Latterich M., Frohlich K.U., Scheckman R. Membrane fusion and the cell cycle: Cdc48p participates in the fusion of ER membranes. Cell 1995, 82:885-893.
19. Rabouille C., Levine T.P., Peters J.M., Warren G. An NSF-like ATPase, p97, and NSF mediate cisternal regrowth from mitotic Golgi fragments. Cell 1995, 82:905-914.
20. Kondo H., Rabouille C., Newman R., Levine T.P., Pappin D., Freemont P., Warren G. p47 is a cofactor for p97-mediated membrane fusion. Nature 1997, 338:75-78.
21. Hetzer M., Meyer H.H., Walther T.C., Bilbao-Cortes D., Warren G., Mattaj I.W. Distinct AAA-ATPase p97 complexes function in discrete steps of nuclear assembly. Nat. Cell Biol. 2001, 3:1086-1091.
22. Ramadan K., Bruderer R., Spiga F.M., Popp O., Baur T., Gotta M., Meyer H.H. Cdc48/p97 promotes reformation of the nucleus by extracting the kinase Aurora B from chromatin. Nature 2007, 450:1258-1262.
23. Ye Y., Meyer H.H., Rapoport T.A. The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 2001, 414:652-656.
24. Jarosch E., Taxis C., Volkwein C., Bordallo J., Finley D., Wolf D.H., Sommer T. Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48. Nat. Cell Biol. 2002, 4:134-139.
25. Rabinovich E., Keren A., Frohlich K.U., Diamant N., Bar Nun S. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol. Cell. Biol. 2002, 22:626-634.
26. Hoppe T., Matuschewski K., Rape M., Schlenker S., Ulrich H.D., Jentsch S. Activation of a membrane-bound transcription factor by regulated ubiquitin/proteasome-dependent processing. Cell 2000, 102:577-586.
27. Dai R.M., Li C.C. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation. Nat. Cell Biol. 2001, 3:740-744.
28. Janiesch R.C., Kim J., Mouysset J., Barikbin R., Lochmuller H., Cassata G., Krause S., Hoppe T. The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly to human myopathy. Nat. Cell Biol. 2007, 9:379-390.
29. Sasagawa Y., Otani M., Higashitani N., Higashitani A., Sato K., Ogura T., Yamanaka K. Caenorhabditis elegans p97 controls germline-specific sex determination by controlling the TRA-1 level in a CUL-2-dependent manner. J. Cell Sci. 2009, 122:3663-3672.
30. Moir D., Stewart S.E., Osmond B.C., Botstein D. Cold-sensitive cell-division-cycle mutations of yeast: isolation, properties, and pseudoreversion studies. Genetics 1982, 100:547-563.
31. Cao K., Nakajima R., Meyer H.H., Zheng Y. The AAA-ATPase Cdc48/p97 regulates spindle disassembly at the end of mitosis. Cell 2003, 115:355-367.
32. Fu X., Ng C., Feng D., Liang C. Cdc48p is required for the cell cycle commitment point at Start via degradation of the G1-CDK inhibitor Far1p. J. Cell Biol. 2003, 163:21-26.
33. Mouysset J., Deichsel A., Moser S., Hoege C., Hyman A.A., Gartner A., Hoppe T. Cell cycle progression requires the CDC-48UFD-1/NPL-4 complex for efficient DNA replication. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:12879-12884.
34. Indig F.E., Patridge J.J., von Kobbe C., Aladjem M.I., Latterich M., Bohr V.A. Werner syndrome protein directly binds to the AAA ATPase p97/VCP in an ATP-dependent fashion. J. Struct. Biol. 2004, 146:251-259.
35. Partridge J.J., Lopreiato J.O., Latterich M., Indig F.E. DNA damage modulates nucleolar interaction of the Werner protein with the AAA ATPase p97/VCP. Mol. Biol. Cell 2003, 14:4221-4229.
36. Higashiyama H., Hirose F., Yamaguchi M., Inoue Y.H., Fujikake N., Matsukage A., Kakizuka A. Identification of ter94, Drosophila VCP, as a modulator of polyglutamine-induced neurodegeneration. Cell Death Differ. 2002, 9:264-273.
37. Kobayashi T., Manno A., Kakizuka A. Involvement of valosin-containing protein (VCP)/p97 in the formation and clearance of abnormal protein aggregates. Genes Cells 2007, 12:889-901.
38. Song C., Wang Q., Li C.C.H. Characterization of the aggregation-prevention activity of p97/VCP-containing protein. Biochemistry 2007, 46:14889-14898.
39. Nishikori S., Yamanaka K., Sakurai T., Esaki M., Ogura T. p97 homologs from Caenorhabditis elegans, CDC-48.1 and CDC-48.2, suppress the aggregate formation of huntingtin exon1 containing expanded polyQ repeat. Genes Cells 2008, 13:827-838.
40. Ju J.S., Fuentealba R.A., Miller S.E., Jackson E., Piwnica-Worms D., Baloh R.H., Weihl C.C. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol. 2009, 187:875-888.
41. Vesa J., Su H., Watts G.D., Krause S., Walter M.C., Martin B., Smith C., Wallace D.C., Kimonis V.E. Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts. Neuromuscul. Disord. 2009, 19:766-772.
42. Tresse E., Salomons F.A., Vesa J., Bott L.C., Kimonis V., Yao T.P., Dantuma N.P., Taylor J.P. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 2010, 6:217-227.
43. Krick R., Bremer S., Welter E., Schlotterhose P., Muehe Y., Eskelinen E.-L., Thumm M. Cdc48/p97 and Shp1/p47 regulate autophagosome biogenesis in concert with ubiquitin-like Atg8. J. Cell Biol. 2010, 190:965-973.
44. Tanaka A., Cleland M.M., Xu S., Narendra D.P., Suen D.F., Karbowski M., Youle R.J. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J. Cell Biol. 2010, 191:1367-1380.
45. Ye Y. Diverse functions with a common regulator: ubiquitin takes command of an AAA ATPase. J. Struct. Biol. 2006, 156:29-40.
46. Schuberth C., Buchberger A. UBX domain proteins: major regulators of the AAA ATPase Cdc48/p97. Cell. Mol. Life Sci. 2008, 65:2360-2371.
47. Madsen L., Seeger M., Semple C.A., Hartmann-Petersen R. New ATPase regulators-p97 goes to the PUB. Int. J. Biochem. Cell Biol. 2009, 41:2380-2388.
48. Watts G.D., Wymer J., Kovach M.J., Mehta S.G., Mumm S., Darvish D., Pestronk A., Whyte M.P., Kimonis V.E. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 2004, 36:377-381.
49. Weihl C.C., Pestronk A., Kimonis V.E. Valosin-containing protein disease: Inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia. Neuromuscul. Disord. 2009, 19:308-315.
50. Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., Ding J., McCluskey L., Martinez-Lage M., Falcone D., Hernandez D.G., Arepalli S., Chong S., Schymick J.C., Rothstein J., Landi F., Wang Y.D., Calvo A., Mora G., Sabatelli M., Monsurrò M.R., Battistini S., Salvi F., Spataro R., Sola P., Borghero G., ITALSGEN Consortium, Galassi G., Scholz S.W., Taylor J.P., Restagno G., Chiò A., Traynor B.J. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 2010, 68:857-864.
51. Wang Q., Song C., Li C.C.H. Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions. J. Struct. Biol. 2004, 146:44-57.
52. Uchiyama K., Kondo H. p97/p47-mediated biogenesis of Golgi and ER. J. Biochem. 2005, 137:115-119.
53. Braun R.J., Zischka H. Mechanisms of Cdc48/VCP-mediated cell death-from yeast apoptosis to human disease. Biochim. Biophys. Acta 2008, 1783:1418-1435.
54. Haines D.S. p97-containing complexes in proliferation control and cancer: emerging culprits or guilt by association?. Genes Cancer 2010, 1:753-763.
55. Chapman E., Fry A.N., Kang M.J. The complexities of p97 function in health and disease. Mol. Biosyst. 2011, 7:700-710.
56. Glickman M.H., Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 2002, 82:373-428.
57. Zhong X., Shen Y., Ballar P., Apostolou A., Agami R., Fang S. AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation. J. Biol. Chem. 2004, 279:45676-45684.
58. Lilley B.N., Ploegh H.L. Multiprotein complexes that link dislocation, ubiquitination, and extraction of misfolded proteins from the endoplasmic reticulum membrane. Proc. Natl. Acad. Sci. U. S. A 2005, 102:14296-14301.
59. Ye Y., Shibata Y., Kikkert M., van Voorden S., Wiertz E., Rapoport T.A. Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:14132-14138.
60. Alexandru G., Graumann J., Smith G.T., Kolawa N.J., Fang R., Deshaies R.J. UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1α turnover. Cell 2008, 134:804-816.
61. Ellis R., Schedl T. Sex determination in the germ line. The C. elegans Research Community April 4 2006, WormBook. http://www.wormbook.org, 10.1895/wormbook.1.82.1. Wormbook (Ed.).
62. Kimble J., Crittenden S.L. Controls of germline stem cells, entry into meiosis, and the sperm/oocytes decision in C. elegans. Annu. Rev. Cell Dev. Biol. 2007, 23:405-433.
63. Mehra A., Gaudet J., Heck L., Kuwabara P.E., Spence A.M. Negative regulation of male development in Caenorhabditis elegans by a protein-protein interaction between TRA-2A and FEM-3. Genes Dev. 1999, 13:1453-1463.
64. Starostina N.G., Lim J.M., Schvarzstein M., Wells L., Spence A.M., Kipreos E.T. A CUL-2 ubiquitin ligase containing three FEM proteins degrades TRA-1 to regulate C. elegans sex determination. Mol. Cell 2007, 13:127-139.
65. Schvarzstein M., Spence A.M. The C. elegans sex-determining GLI protein TRA-1A is regulated by sex-specific proteolysis. Dev. Cell 2006, 11:733-740.
66. Yamauchi S., Yamanaka K., Ogura T. Comparative analysis of expression of two p97 homologues in Caenorhabditis elegans. Biochem. Biophys. Res. Commun. 2006, 345:746-753.
67. Yamauchi S., Higashitani N., Otani M., Higashitani A., Ogura T., Yamanaka K. Involvement of HMG-12 and CAR-1 in the cdc-48.1 expression of Caenorhabditis elegans. Dev. Biol. 2008, 318:348-359.
68. Sasagawa Y., Yamanaka K., Saito-Sasagawa Y., Ogura T. Caenorhabditis elegans UBX cofactors for CDC-48/p97 control spermatogenesis. Genes Cells 2010, 15:1201-1215.
69. Shcherbik N., Zoladek T., Nickels J.T., Haines D.S. Rsp5p is required for ER bound Mga2p120 polyubiquitination and release of the processed/tethered transactivator Mga2p90. Curr. Biol. 2003, 13:1227-1233.
70. Npl4p/Ufd1p binds and segregates membrane-anchored/tethered complexes via a polyubiquitin signal present on the anchors. Mol. Cell 2007, 25:385-397.
71. Sowa M.E., Bennett E.J., Gygi S.P., Harper J.W. Defining the human deubiquitinating enzymes interaction land scape. Cell 2009, 138:389-403.
72. Kawaguchi Y., Okamoto T., Taniwaki M., Aizawa M., Inoue M., Katayama S., Kawakami H., Nakamura S., Nishimura M., Akiguchi I. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet. 1994, 8:221-228.
73. Burnett B., Li F., Pittman R.N. The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Hum. Mol. Genet. 2003, 12:3195-3205.
74. Doss-Pepe E.W., Stenroos E.S., Johnson W.G., Madura K. Ataxin-3 interactions with Rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis. Mol. Cell. Biol. 2003, 23:6469-6483.
75. Zhong X., Pittman R.N. Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates. Hum. Mol. Genet. 2006, 15:2409-2420.
76. Wang Q., Li L., Ye Y. Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3. J. Cell Biol. 2006, 174:963-971.
77. Fernandez-Saiz V., Buchberger A. Imbalances in p97 co-factor interactions in human proteinopathy. EMBO Rep. 2010, 11:479-485.
78. Kuhlbrodt K., Janiesch P.C., Kevei E., Segref A., Barikbin R., Hoppe T. The Machado-Joseph disease deubiquitylase ATX-3 couples longevity and proteostasis. Nat. Cell Biol. 2011, 13:272-281.
79. Leidhold C., Voos W. Chaperones and proteases-guardians of protein integrity in eukaryotic organelles. Ann. N. Y. Acad. Sci. 2007, 1113:72-86.
80. Zhong Q., Gao W., Du F., Wang X. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 2005, 121:108501095.
81. Neutzner A., Youle R.J., Karbowski M. Outer mitochondrial membrane protein degradation by the proteasome. Novartis Found Symp. 2007, 287:4-14.
82. Ziviani E., Tao R.N., Whitworth A.J. Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:5018-5023.
83. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392:605-608.
84. Narendra D., Tanaka A., Suen D.F., Youle R.J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 2008, 183:795-803.
85. Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai N., Chiba T., Tanaka K., Suzuki T. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 2000, 25:302-305.
86. Nakamura N., Hirose S. Regulation of mitochondrial morphology by USP30, a deubiquitinating enzyme present in the mitochondrial outer membrane. Mol. Biol. Cell 2008, 19:1903-1911.
87. Krogan N.J., Cagney G., Yu H., Zhong G., Guo X., Ignatchenko A., Li J., Pu S., Datta N., Tikuisis A.P., Punna T., Peregrín-Alvarez J.M., Shales M., Zhang X., Davey M., Robinson M.D., Paccanaro A., Bray J.E., Sheung A., Beattie B., Richards D.P., Canadien V., Lalev A., Mena F., Wong P., Starostine A., Canete M.M., Vlasblom J., Wu S., Orsi C., Collins S.R., Chandran S., Haw R., Rilstone J.J., Gandi K., Thompson N.J., Musso G., St Onge P., Ghanny S., Lam M.H., Butland G., Altaf-Ul A.M., Kanaya S., Shilatifard A., O'Shea E., Weissman J.S., Ingles C.J., Hughes T.R., Parkinson J., Gerstein M., Wodak S.J., Emili A., Greenblatt J.F. Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature 2006, 440:637-643.
88. Hao H.X., Rutter J. Revealing human disease genes through analysis of the yeast mitochondrial proteome. Cell Cycle 2009, 8:4007-4008.
89. Heo J.M., Livnat-Levanon N., Taylor E.B., Jones K.T., Dephoure N., Ring J., Xie J., Brodsky J.L., Madeo F., Gygi S.P., Ashrafi K., Glickman M.H., Rutter J. A stress-responsive system for mitochondrial protein degradation. Mol. Cell 2010, 40:465-480.
90. Tran J.R., Tomsic L.R., Brodsky J.L. A Cdc48p-associated factor modulates endoplasmic reticulum-associated degradation, cell stress, and ubiquitinated protein homeostasis. J. Biol. Chem. 2011, 286:5744-5755.
91. Xu S., Peng G., Wang Y., Fang S., Karbowski M. The AAA-ATPase p97 is essential for outer mitochondrial membrane protein turnover. Mol. Biol. Cell 2011, 22:291-300.
92. Pallanck L.J. Culling sick mitochondria from the herd. J. Cell. Biol. 2010, 191:1225-1227.
93. Guinto J.B., Ritson G.P., Taylor J.P., Forman M.S. Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy. Acta Neuropathol. 2007, 114:55-61.
94. Kimonis V.E., Fulchiero E., Vesa J., Watts G. VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. Biochim. Biophys. Acta 2008, 1782:744-748.
95. Ju J.S., Weihl C.C. Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy. Hum. Mol. Genet. 2010, 19:R38-R45.
96. DeLaBarre B., Brunger A.T. Nucleotide dependent motion and mechanism of action of p97/VCP. J. Mol. Biol. 2005, 347:437-452.
97. Hubbers C.U., Clemen C.S., Kesper K., Boddrich A., Hoffmann A., Kamarainen O., Tolksdorf K., Stumpf M., Reichelt J., Roth U., Krause S., Watts G., Kimonis V., Wattjes M.P., Reimann J., Thal D.R., Biermann K., Evert B.O., Lochmuller H., Wanker E.E., Schoser B.G., Noegel A.A., Schroder R. Pathological consequences of VCP mutations on human striated muscle. Brain 2007, 130:381-393.
98. Tang W.K., Li D., Li C.C., Esser L., Dai R., Guo L., Xia D. A novel ATP-dependent conformation in p97 N-D1 fragment revealed by crystal structures of disease-related mutants. EMBO J. 2010, 29:2217-2229.
99. Manno A., Noguchi M., Fukushi J., Motohashi Y., Kakizuka A. Enhanced ATPase activities as a primary defect of mutant valosin-containing proteins that cause inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. Genes Cells 2010, 15:911-922.
100. Halawani D., LeBlanc A.C., Rouiller I., Michnick S.W., Servant M.J., Latterich M. Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation. Mol. Cell. Biol. 2009, 29:4484-4494.
101. Weihl C.C., Dalal S., Pestronk A., Hanson P.I. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. Hum. Mol. Genet. 2006, 15:189-199.
102. Ju J.S., Miller S.E., Hanson P.I., Weihl C.C. Impaired protein aggregate handling and clearance underlie the pathogenesis of p97/VCP-associated disease. J. Biol. Chem. 2008, 283:30289-30299.
103. Dalal S., Rosser M.F., Cyr D.M., Hanson P.I. Distinct roles for the AAA ATPases NSF and p97 in the secretory pathway. Mol. Biol. Cell 2004, 15:637-648.
104. Wojcik C., Yano M., DeMartino G.N. RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysis. J. Cell Sci. 2004, 117:281-292.
105. Glick D., Barth S., Macleod K.F. Autophagy: cellular and molecular mechanisms. J. Pathol. 2010, 221:3-12.
106. Weihl C.C., Miller S.E., Hanson P.I., Pestronk A. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice. Hum. Mol. Genet. 2007, 16:919-928.
107. Badadani M., Nalbandian A., Watts G.D., Vesa J., Kitazawa M., Su H., Tanaja J., Dec E., Wallace D.C., Mukherjee J., Caiozzo V., Warman M., Kimonis V.E. VCP associated inclusion body myopathy and Paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease. PLoS ONE 2010, 5:e13183.
108. Neumann M., Mackenzie I.R., Cairns N.J., Boyer P.L., Markesbery W.R., Smith C.D., Taylor J.P., Kretzschmar H.A., Kimonis V.E., Forman M.S. TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J. Neuropathol. Exp. Neurol. 2007, 66:152-157.
109. Weihl C.C., Temiz P., Miller S.E., Watts G., Smith C., Forman M., Hanson P.I., Kimonis V., Pestronk A. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 2008, 79:1186-1189.
110. Forman M.S., Mackenzie I.R., Cairns N.J., Swanson E., Boyer P.J., Drachman D.A., Jhaveri B.S., Karlawish J.H., Pestronk A., Smith T.W., Tu P.H., Watts G.D., Markesbery W.R., Smith C.D., Kimonis V.E. Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J. Neuropathol. Exp. Neurol. 2006, 65:571-581.
111. Ayala Y.M., Pantano S., D'Ambrogio A., Buratti E., Brindisi A., Marchetti C., Romano M., Baralle F.E. Human, Drosophila, and C. elegans TDP43: nucleic acid binding properties and splicing regulatory function. J. Mol. Biol. 2005, 348:575-588.
112. Warraich S.T., Yang S., Nicholson G.A., Blair I.P. TDP-43: A DNA and RNA binding protein with roles in neurodegenerative diseases. Int. J. Biochem. Cell Biol. 2010, 42:1606-1609.
113. Lagier-Tourenne C., Polymenidou M., Cleveland D.W. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 2010, 19:R46-R64.
114. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
115. Ayala Y.M., Zago P., D'Ambrogio A., Xu Y.F., Petrucelli L., Buratti E., Baralle F.E. Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci. 2008, 121:3778-3785.
116. Winton M.J., Igaz L.M., Wong M.M., Kwong L.K., Trojanowski J.Q., Lee V.M. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 2008, 283:13302-13309.
117. Wang X., Fan H., Ying Z., Li B., Wang H., Wang G. Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system. Neurosci. Lett. 2010, 469:112-116.
118. Ritson G.P., Custer S.K., Freibaum B.D., Guinto J.B., Geffel D., Moore J., Tang W., Winton M.J., Neumann M., Trojanowski J.Q., Lee V.M.-Y., Forman M.S., Taylor J.P. TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. J. Neurosci. 2010, 30:7729-7739.
119. Geser F., Martinez-Lage M., Kwong L.K., Lee V.M., Trojanowski J.Q. Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 disease. J. Neurol. 2009, 256:1205-1214.
120. Miguel L., Frebourg T., Campion D., Lecourtois M. Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies. Neurobiol. Dis. 2011, 41:398-406.
121. Chang Y.C., Hung W.T., Chang Y.C., Chang H.C., Chiang A.S., Jackson G.R., Sang T.K. Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in Drosophila IBMPFD model. PLoS Genet. 2011, 7:e1001288.
122. Greenberg S.A., Watts G.D., Kimonis V.E., Amato A.A., Pinkus J.L. Nuclear localization of valosin-containing protein in normal muscle and muscle affected by inclusion-body myositis. Muscle Nerve 2007, 36:447-454.
123. Deichsel A., Mouysset J., Hoppe T. The ubiquitin-selective chaperone CDC-48/p97, a new player in DNA replication. Cell Cycle 2009, 8:185-190.
124. Meyer H., Drozdowska A., Dobrynin G. A role for CDC48/p97 and Aurora B in controlling chromatin condensation during exit from mitosis. Biochem. Cell Biol. 2010, 88:23-28.
125. Ikai N., Yanagida M. Cdc48 is required for the stability of Cut1/separase in mitotic anaphase. J. Struct. Biol. 2006, 156:50-61.
126. Hsu J.Y., Sun Z.W., Li X., Reuben M., Tatchell K., Bishop D.K., Grushcow J.M., Brame C.J., Caldwell J.A., Hunt D.F., Lin R., Smith M.M., Allis C.D. Mitotic phosphorylation of histonH3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell 2000, 102:279-291.
127. Dobrynin G., Popp O., Romer T., Bremer S., Schmitz M.H.A., Gerlich D.W., Meyer H. Cdc48/p97-Ufd1-Npl4 antagonizes Aurora B during chromosome segregation in HeLa cells. J. Cell Sci. 2011, 124:1571-1580.
128. Cheng Y.L., Chen R.H. The AAA-ATPase Cdc48 and cofactor Shp1 promote chromosome bi-orientation by balancing Aurora B activity. J. Cell Sci. 2010, 123:2025-2034.
129. Pasierbek P., Jantsch M., Melcher M., Schleiffer A., Schweizer D., Loidl J. A Caenorhabditis elegans cohesion protein with functions in meiotic chromosome pairing and disjunction. Genes Dev. 2001, 15:1349-1360.
130. Rogers E., Bishop J.D., Waddle J.A., Schumacher J.M., Lin R. The aurora kinase AIR-2 functions in the release of chromosome cohesion in Caenorhabditis elegans meiosis. J. Cell Biol. 2002, 157:219-229.
131. Sasagawa Y., Yamanaka K., Nishikori S., Ogura T. Caenorhabditis elegans p97/CDC-48 is critical for progression of meiosis I. Biochem. Biophys. Res. Commun. 2007, 358:920-924.
132. Heubes S., Stemmann O. The AAA-ATPase p97-Ufd1-Npl4 is required for ERAD but not for spindle disassembly in Xenopus egg extracts. J. Cell Sci. 2007, 120:1325-1329.
133. Yamada T., Okuhara K., Iwamatsu A., Seo H., Shibata T., Murofushi H. p97 ATPase, an ATPase involved in membrane fusion, interacts with DNA unwinding factor (DUF) that functions in DNA replication. FEBS Lett. 2000, 466:289-291.
134. Caruso M.E., Jenna S., Bouchecareilh M., Baillie D.L., Boismenu D., Halawani D., Latterich M., Chevet E. GTPase-mediated regulation of the unfolded protein response in Caenorhabditis elegans is dependent on the AAA+ ATPase CDC-48. Mol. Cell. Biol. 2008, 28:4261-4274.
135. Verma R., Oania R., Fang R., Smith G.T., Deshaies R.J. Cdc48/p97 mediates UV-dependent turnover of RNA Pol II. Mol. Cell 2011, 41:82-92.
136. Wang Q., Li L., Ye Y. Inhibition of p97-dependent protein degradation by eeyarestatin I. J. Biol. Chem. 2008, 283:7445-7454.
137. Wang Q., Shinkre B.A., Lee J., Weniger M.A., Liu Y., Chen W., Wiestner A., Trenkle W.C., Ye Y. The ERAD inhibitor eeyarestatin I is a bifunctional compound with a membrane-binding domain and a p97/VCP inhibitory group. PLoS ONE 2010, 5:e15479.
138. Bursavich M.G., Parker D.P., Willardsen J.A., Gao Z.H., Davis T., Ostanin K., Robinson R., Peterson A., Cimbora D.M., Zhu J.F., Richards B. 2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97). Bioorg. Med. Chem. Lett. 2010, 20:1677-1679.
139. Chou T.F., Dashaies R.J. Quantitative cell-based protein degradation assays to identify and classify drugs that target the ubiquitin-proteasome system. J. Biol. Chem. 2011, 286:16546-16554.
140. Chou T.F., Brown S.J., Minond D., Nordin B.E., Li K., Jones A.C., Chase P., Porubsky P.R., Stoltz B.M., Schoenen F.J., Patricelli M.P., Hodder P., Rosen H., Deshaies R.J. Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways. Proc. Natl. Sci. Acad. U. S. A. 2011, 108:4834-4839.
141. Cubedo E., Cordeu L., Bandres E., Rebollo A., Malumbres R., Sanmartin C., Font M., Palop J.A., Garcia-Foncillas J. New symmetrical quinazoline derivatives selectively induce apoptosis in human cancer cells. Cancer Biol. Ther. 2006, 5:850-859.
142. Adams J. The development of proteasome inhibitors as anticancer drugs. Cancer Cell 2004, 5:417-421.
143. Yamamoto S., Tomita Y., Hoshida Y., Takiguchi S., Fujiwara Y., Yasuda T., Yano M., Nakamori S., Sakon M., Monden M., Aozasa K. Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma. J. Clin. Oncol. 2003, 21:2537-2544.
144. Yamamoto S., Tomita Y., Uruno T., Hoshida Y., Qiu Y., Iizuka N., Nakamichi I., Miyauchi A., Aozasa K. Increased expression of valosin-containing protein (p97) is correlated with disease recurrence in follicular thyroid cancer. Ann. Surg. Oncol. 2005, 12:925-934.